Gerald G. Wulf

Robert Koch Str. 40
Goettingen, NI 37075, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 187 publications

In Search of Long-Term Disease Control: CAR T-Cell Therapy With Axicabtagene Ciloleucel or Allogeneic Hematopoietic Cell Transplantation Against Relapsed/Refractory Large B-Cell Lymphoma.

In Search of Long-Term Disease Control: CAR T-Cell Therapy With Axicabtagene Ciloleucel or Allogeneic Hematopoietic Cell Transplantation Against Relapsed/Refractory Large B-Cell Lymphoma.

Journal: Clinical lymphoma, myeloma & leukemia

Published: June 21, 2026

Viable CAR T-cells remain detectable in cerebrospinal fluid in patients with grade ≥3 ICANS despite corticosteroid therapy.

Viable CAR T-cells remain detectable in cerebrospinal fluid in patients with grade ≥3 ICANS despite corticosteroid therapy.

Journal: Frontiers in oncology

Published: March 30, 2026

Epcoritamab in Richter transformation: insights from a real-world case series.

Epcoritamab in Richter transformation: insights from a real-world case series.

Journal: Blood advances

Published: March 18, 2026

Epcoritamab in Richter Transformation: Insights from a Real-World Case Series.

Epcoritamab in Richter Transformation: Insights from a Real-World Case Series.

Journal: Blood advances

Published: March 18, 2026

Timing of donor lymphocyte infusion after relapse following allogeneic hematopoietic cell transplantation: a retrospective single-center analysis.

Timing of donor lymphocyte infusion after relapse following allogeneic hematopoietic cell transplantation: a retrospective single-center analysis.

Journal: Annals of hematology

Published: March 09, 2026

Δ-β2M as a dynamic biomarker for predicting ICU admission after CAR T-cell therapy.

Δ-β2M as a dynamic biomarker for predicting ICU admission after CAR T-cell therapy.

Journal: Annals of hematology

Published: March 02, 2026

Impact of fludarabine dosage on outcomes in large B-cell lymphoma patients treated with CAR T-cell therapy: a retrospective study of the CTIWP of the EBMT.

Impact of fludarabine dosage on outcomes in large B-cell lymphoma patients treated with CAR T-cell therapy: a retrospective study of the CTIWP of the EBMT.

Journal: Bone marrow transplantation

Published: March 02, 2026

Reducing prescription errors in oncological systemic therapies by implementing software-assisted therapy planning

Reducing prescription errors in oncological systemic therapies by implementing software-assisted therapy planning

Journal: Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen

Published: February 10, 2026

The impact of IPI risk factors on CAR T-cell therapy or allogeneic stem cell transplantation for treatment of relapsed or refractory large B-cell lymphoma (LBCL).

The impact of IPI risk factors on CAR T-cell therapy or allogeneic stem cell transplantation for treatment of relapsed or refractory large B-cell lymphoma (LBCL).

Journal: Bone marrow transplantation

Published: February 02, 2026

Long-Term Clinical and Molecular Dynamics in Hypoplastic Myelodysplastic Neoplasia Treated With Immunosuppressive Therapy.

Long-Term Clinical and Molecular Dynamics in Hypoplastic Myelodysplastic Neoplasia Treated With Immunosuppressive Therapy.

Journal: European journal of haematology

Published: January 28, 2026

Simultaneous measurement of target and effector cell death, apoptosis, and proliferation in cell therapy development using flow cytometry.

Simultaneous measurement of target and effector cell death, apoptosis, and proliferation in cell therapy development using flow cytometry.

Journal: STAR protocols

Published: January 16, 2026

Allogeneic stem cell transplantation for major T-cell lymphoma entities: an analysis of the EBMT-lymphoma working party.

Allogeneic stem cell transplantation for major T-cell lymphoma entities: an analysis of the EBMT-lymphoma working party.

Journal: Journal of hematology & oncology

Published: December 27, 2025

Showing 1-12 of 187

Last Updated: 09/26/2026